Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias. - Wikidata - wikimedia - TriplyDB

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

http://www.wikidata.org/entity/Q37821496

about

Light chain deposition disease: novel biological insights and treatment advances.Association between left ventricular function and paraprotein type in patients with multiple myeloma.

P2860

Q37999472-7B5FB565-99D2-48CF-8463-8881D9EAC241 Q42264104-08E37EE4-B94F-4216-98FD-73F909097A06

P2860

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

http://www.wikidata.org/entity/Q37821496

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

@en

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

@nl

type

label

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

@en

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

@nl

prefLabel

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

@en

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

@nl

P1433

Q37821496-68ED261D-B5E3-4C78-AB3E-F7D88B5A094E

P1476

Q37821496-B564DC68-FF38-4AC2-A15B-4902982199AC

P2093

Q37821496-C1E651C8-CC7C-419B-8B50-29863FDB47A7

P2860

Q37821496-03F8FD13-8D1F-425D-8214-07F6021B1ECE

Q37821496-06749B7A-E8B6-45A5-9418-090C90EAD96B

Q37821496-0F1744E7-28B8-4511-9164-C9455C4CA65F

Q37821496-0FA1D360-46C0-4D75-89E0-8A083AA03ED2

Q37821496-29A38806-FFFE-498F-AA2E-477FE6B32527

Q37821496-2D8072BD-45BD-4722-B6BC-26C496AB957F

Q37821496-30A67A11-E064-47FE-BD1A-5CBB45FA527E

Q37821496-3D2441E4-C701-46D3-926B-E3023ADE965A

Q37821496-40270850-3F06-44E7-A95D-68193202053C

Q37821496-45FBD6E2-EB6D-44E6-8835-288502EC2B44

P304

Q37821496-CF9F6E51-F961-4AC9-8414-5526A28377A9

P31

Q37821496-47F54F73-4C1D-4370-B360-B541BA08A8C2

Q37821496-68256238-6929-425d-a192-142830cdd8c3

P356

Q37821496-E2A6475A-65BC-4EB7-AE80-392F0CD5C0BD

P433

Q37821496-A6BEFB8B-345A-45E5-BE18-67D166BE862C

P478

Q37821496-799D55CC-8F68-4758-8FC6-0F6A44F03869

P50

Q37821496-91E59CAF-02B1-461D-9EFA-5D1E0DD485C4

P577

Q37821496-7777D855-F2E1-4E2E-BB4D-7A87757BEF03

P698

Q37821496-1C068A14-288E-4156-B352-41515EAB1F11

P356

P1433

Expert Review of Clinical Immunology

P1476

Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.

@en

P2093

Guner Hayri Ozsan

http://www.w3.org/2001/XMLSchema#string

P2860

Appraisal of immunoglobulin free light chain as a marker of response

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins

Immunoglobulin free light chains and solitary plasmacytoma of bone

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

P304

65-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECI.10.80

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Angela Dispenzieri

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21162651

http://www.w3.org/2001/XMLSchema#string